Skip to content

Clinical trials

Basal Cell Carcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Country / region: Netherlands Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20132
20141
20152
20171
20193
20202
20212
20221
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status7
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center14
Hoffmann-La Roche2
Sol-Gel Technologies, Ltd.2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Novartis Pharmaceuticals1
Radboud University Medical Center1
Regeneron Pharmaceuticals1
University Hospital, Ghent1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma23
Basal Cell Nevus Syndrome3
Carcinoma2
Cutaneous Squamous Cell Carcinoma2
Neoplasms, Basal Cell2
Recurrence2
Skin Neoplasms2
Carcinoma, Squamous Cell1
Connective Tissue Diseases1
Disease1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.